Article PDF
Avoid common mistakes on your manuscript.
References
Vaughan Williams EM. Electrophysiological basis for a rational approach to antidysrhythmic drug therapy.In: Harper, NJ, Simmonds, AB (Eds.): Advances in Drug Research. Academic Press, London, 1974.
Harrison DC. Symposium on perspectives on the treatment of ventricular arrhythmias. Introduction. Am J Cardiol 1983; 52: lc-2c.
Pottage A. Clinical profiles of newer class I antiarrhythmic agents — tocainide, mexiletine, encainide, flecainide and lorcainide. Am J Cardiol 1983; 52: 24c-31c.
Siddoway LA, Roden DM, Woosley RL. Clinical pharmacology of old and new antiarrhythmic drugs.In: Sudden cardiac death. Cardiovascular Clinics. FA Davis, 1985; 199–248.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roy, D. Antiarrhythmic drugs. Can Anaesth Soc J 33 (Suppl 1), S65–S67 (1986). https://doi.org/10.1007/BF03019159
Issue Date:
DOI: https://doi.org/10.1007/BF03019159